🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Delayed Cerebral Infarction Beyond Endoluminal Spasmolysis and Induced Hypertension

Recruitingn/aAges 18 Years - anyAllRegion Stockholm
NCT07305922 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

An observational study of patients with emerging or established severe cerebral vasospasm after subarachnoid haemorrhage, employing multimodal neuromonitoring.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adults 18 years or older * Critical care after subarachnoid haemorrhage * Aneurysm secured by surgical clipping or endovascular procedure * Suspected, emerging or established severe cerebral vasospasm Exclusion Criteria: * Anticipated survival less than five days, as determined by treating clinician * Transcranial Doppler signal too weak * Pregnancy
💊

What it tests

  • Induced hypertension with norepinephrine
  • Endoluminal Spasmolysis
📍

Where

1 site
Karolinska University Hospital
Stockholm, Sweden
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy